medigraphic.com
Organo Oficial de la Sociedad Mexicana de Urología

2024, Número 1

<< Anterior Siguiente >>

Rev Mex Urol 2024; 84 (1)


Etiología, patogénesis, diagnóstico y tratamiento de la cistitis y pielitis incrustada: Revisión del problema desde una perspectiva histórica

Soriano-García F, Fernández-Natal I

Idioma: Ingles.
Referencias bibliográficas: 50
Paginas: 1-12
Archivo PDF: 245.58 Kb.


RESUMEN

Introducción: La cistitis incrustada y la pielitis comparten muchas similitudes con respecto a etiología, patogénesis, diagnóstico y tratamiento. Estos procesos suelen ocurrir sobre un tejido urológico previamente lesionado con la participación de una infección por bacterias productoras de ureasa. En el momento actual, Corynebacterium urealyticum, una bacteria altamente resistente a los antibióticos parece ser el patógeno que más a menudo se ve involucrado en estos procesos. En esta revisión analizamos la historia de estas enfermedades remarcando los avances científicos del último siglo. También revisamos el papel de la ureasa y de la infección bacteriana, así como una breve actualización de los aspectos epidemiológicos, histopatológicos, diagnósticos y terapéuticos.
Relevancia: Se desea remarcar la importancia y gravedad de estas patologías que son frecuentemente infradiagnosticadas y que son de difícil tratamiento.
Conclusiones: La historia clínica, datos exploratorios y analíticos en donde destaca una orina alcalina, a veces con olor amoniacal, piuria, hematuria y presencia de cristales de fosfato amónico magnésico debe alertar al urólogo sobre la existencia de una uropatía incrustante. La radiología simple, ecografía, tomografía computarizada y la visualización endoscópica de las lesiones confirman el diagnóstico. El tratamiento generalmente precisa de cirugía, uso de antibióticos, acidificantes urinarios e inhibidores de la ureasa bacteriana.


REFERENCIAS (EN ESTE ARTÍCULO)

  1. Griffith DP. Struvite stones. Kidney International.1978;13(5): 372–382. https://doi.org/10.1038/ki.1978.55.

  2. Françoise J. La cystite incrustée. J Urol Méd Chir.1914;14(5): 35–52.

  3. Aguado JM, Morales JM, Salto E, Lumbreras C,Lizasoain M, Diaz-Gonzalez R, et al. Encrustedpyelitis and cystitis by corynebacteriumurealyticum (CDC group D2): a new andthreatening complication following renaltransplant. Transplantation. 1993;56(3):617–622. https://doi.org/10.1097/00007890-199309000-00023.

  4. Griffith DP, Musher DM. Prevention of infectedurinary stones by urease inhibition. InvestigativeUrology. 1973;11(3): 228–233.

  5. Soriano F, Ponte C, Santamaría M, Castilla C,Fernández Roblas R. In vitro and in vivo studyof stone formation by Corynebacterium groupD2 (Corynebacterium urealyticum). Journalof Clinical Microbiology. 1986;23(4): 691–694. https://doi.org/10.1128/jcm.23.4.691-694.1986.

  6. Soriano F, Tauch A. Microbiological and clinicalfeatures of Corynebacterium urealyticum:urinary tract stones and genomics as the RosettaStone. Clinical Microbiology and Infection.2008;14(7): 632–643. https://doi.org/10.1111/j.1469-0691.2008.02023.x.

  7. Braude AI, Siemienski J. Role of bacterial ureasein experimental pyelonephritis1. Journal ofBacteriology. 1960;80(2): 171–179. https://doi.org/10.1128/jb.80.2.171-179.1960.

  8. Schaffer JN, Pearson MM. Proteus mirabilis andUrinary Tract Infections. Mulvey MA, StapletonAE, Klumpp DJ (eds.) Microbiology Spectrum.2015;3(5): 3.5.10. https://doi.org/10.1128/microbiolspec.uti-0017-2013.

  9. Resnick MI. Evaluation and Management ofInfection Stones. Urologic Clinics of NorthAmerica. 1981;8(2): 265–276. https://doi.org/10.1016/S0094-0143(21)01281-7.

  10. Hager B, Magath T. The etiology of incrustedcystitis with alkaline urine. Journal of theAmerican Medical Association. 1925;85(18):1352–1355. https://doi.org/10.1001/jama.1925.02670180008002.

  11. Shaw EC, Hill JH. Report of a New PathogenicOrganism (Co-Rynebacterium Thompsoni)with Description of an Epidemic of Infection ofUrinary Fistula. Journal of Urology. 1925;13(6):689–713. https://doi.org/10.1016/S0022-5347(17)73606-3.

  12. Randall A, Campbell EW. Alkaline IncrustedCystitis1. Journal of Urology. 1937;37(2):284–298. https://doi.org/10.1016/S0022-5347(17)72029-0.

  13. Burns E. The role of urea-splitting organismsin the formation of certain types of stonesin the urinary tract. Surgery. 1938;4(5):673–679. https://doi.org/10.5555/uri:pii:S0039606038903836.

  14. Thompson L, Schulte TL. Urea-splittingorganisms in urine: preliminary report. In: Proc.Staff Meet., Mayo Clin. 1939. p. 361–364.

  15. Cifuentes Delatte, L . Cistitis y cistopatías. PazMontalvo; 1947.

  16. Jameson RM. The treatment of phosphaticencrusted cystitis (alkaline cystitis) withnalidixic acid. British Journal of Urology.1966;38(1): 89–92. https://doi.org/10.1111/j.1464-410x.1966.tb09682.x.

  17. Marsh FP, Vince FP, Pollock DJ, Path MC, BlandyJP, Chir. M. Cyclophosphamide necrosis ofbladder causing calcification, contracture andreflux; treated by colocystoplasty. British Journalof Urology. 2008;43(3): 324–332. Doi: https://doi.org/10.1111/j.1464-410x.1971.tb12049.x

  18. Rodríguez Tolrá JR, Serrate R. Cistitisincrustante. Archivos Españoles De Urologia.

  19. 1978;31: 541–556.19. Aubert J, Dore B, Touchard G, Loetitia G. Lacystite incrustée à urine alcaline. Aspectscliniques et traitement. Journal d’urologie.1982;88(6): 359–363.

  20. Hedelin H, Brorson J -E., Grenabo L, PetterssonS. Ureaplasma urealyticum and Upper UrinaryTract Stones. British Journal of Urology.1984;56(3): 244–249. https://doi.org/10.1111/j.1464-410x.1984.tb05381.x.

  21. Braude Ai, Siemienski J, Jacobs I. Protoplastformation in human urine. Transactions of theAssociation of American Physicians. 1961;74.https://pubmed.ncbi.nlm.nih.gov/13872570/

  22. Ribot S, Gal K, Goldblat MV, Eslami HH. TheRole of Anaerobic Bacteria in the Pathogenesisof Urinary Tract Infections. Journal ofUrology. 1981;126(6): 852–853. https://doi.org/10.1016/s0022-5347(17)54781-3.

  23. Soriano F, Ponte C, Santamaria M, Aguado JM,Wilhelmi I, Vela R, et al. Corynebacterium groupD2 as a cause of alkaline-encrusted cystitis:report of four cases and characterization ofthe organisms. Journal of Clinical Microbiology.1985;21(5): 788–792. https://doi.org/10.1128/jcm.21.5.788-792.1985.

  24. 24.Pitcher D, Soto A, Soriano F, Valero-GuillenP. Classification of Coryneform BacteriaAssociated with Human Urinary Tract Infection(Group D2) as Corynebacterium urealyticumsp. nov. International Journal of SystematicBacteriology. 1992;42(1): 178–181. https://doi.org/10.1099/00207713-42-1-178.

  25. Soriano F, Fernández-Natal I. Corynebacteriumurealyticum: un patógeno frecuentementeresponsable de casos de cistitis y pielitisincrustadas. Revista Mexicana de Urología.2023;83(4): 1–4. https://doi.org/10.48193/revistamexicanadeurologa.v83i4.1030.

  26. Aguado JM, Ponte C, Soriano F. Bacteriuria witha Multiply Resistant Species of Corynebacterium(Corynebacterium Group D2): An UnnoticedCause of Urinary Tract Infection. Journal ofInfectious Diseases. 1987;156(1): 144–150.https://doi.org/10.1093/infdis/156.1.144.

  27. Soriano F, Aguado JM, Ponte C, Fernández-Roblas R, Rodríguez-Tudela JL. Urinary TractInfection Caused by Corynebacterium GroupD2: Report of 82 Cases and Review. ClinicalInfectious Diseases. 1990;12(6): 1019–1034.https://doi.org/10.1093/clinids/12.6.1019.

  28. Meria P, Desgrippes A, Arfi C, Le Duc A.Encrusted cystitis and pyelitis. The Journal ofUrology. 1998;160(1): 3–9.

  29. Sakhi H, Join-Lambert O, Goujon A, Culty T,Loubet P, Dang J, et al. Encrusted Urinary TractInfections Due to Corynebacteria Species. KidneyInternational Reports. 2021;6(1): 179–186.https://doi.org/10.1016/j.ekir.2020.10.034.

  30. Devine PA, Courtney AE. Alkaline-EncrustedPyelitis in a Renal Allograft. Kidney InternationalReports. 2019;4(1): 174–177. https://doi.org/10.1016/j.ekir.2018.08.012.

  31. Ito K, Takahashi T, Kanno T, Okada T, HigashiY, Yamada H. Renal failure due to encrustedcystitis and pyelitis. IJU Case Reports. 2020;3(3):112–115. https://doi.org/10.1002/iju5.12158.

  32. Fernández Natal I, Cachón García F, Guerra LasoJ, Alcoba Leza M, Soriano García F. BacteremiaCaused by Multiply Resistant Corynebacteriumurealyticum: Six Case Reports and Review.European Journal of Clinical Microbiology andInfectious Diseases. 2001;20(7): 514–517.https://doi.org/10.1007/pl00011297.

  33. Meria P, Margaryan M, Haddad E, Dore B,Lottmann HB. Encrusted cystitis and pyelitis inchildren: An unusual condition with potentiallysevere consequences. Urology. 2004;64(3):569–573. https://doi.org/10.1016/j.urology.2004.04.013.

  34. Soriano F, Rodriguez-Tudela JL, Fernández-Roblas R, Aguado JM, Santamaría M. Skincolonization by Corynebacterium groups D2and JK in hospitalized patients. Journal of ClinicalMicrobiology. 1988;26(9): 1878–1880. https://doi.org/10.1128/jcm.26.9.1878-1880.1988.

  35. Van De Perre E, Reichman G, De Geyter D,Geers C, Wissing KM, Letavernier E. EncrustedUropathy: A Comprehensive Overview—Tothe Bottom of the Crust. Frontiers in Medicine.2021;7: 609024. https://doi.org/10.3389/fmed.2020.609024.

  36. Sánchez-Martín FM, López-Martínez JM,Kanashiro-Azabache A, Moncada E, Angerri-FeuO, Millán-Rodríguez F, et al. Corynebacteriumurealyticum: aumento de la incidencia deinfección y uropatía incrustante. ActasUrológicas Españolas. 2016;40(2): 102–107.https://doi.org/10.1016/j.acuro.2015.09.007.

  37. Lopez-Medrano F, Garcia-Bravo M, MoralesJM, Andras A, San Juan R, Lizasoain M, et al.Urinary Tract Infection due to Corynebacteriumurealyticum in Kidney Transplant Recipients:An Underdiagnosed Etiology for ObstructiveUropathy and Graft Dysfunction--Results of aProspective Cohort Study. Clinical InfectiousDiseases. 2008;46(6): 825–830. https://doi.org/10.1086/528713.

  38. Cappuccino L, Bottino P, Torricella A, PontremoliR. Nephrolithiasis by Corynebacteriumurealyticum infection: literature review andcase report. Journal of Nephrology. 2014;27(2):117–125. https://doi.org/10.1007/s40620-014-0064-1.

  39. Pierciaccante A, Pompeo ME, Fabi F, VendittiM. Successful treatment of Corynebacteriumurealyticum encrusted cystitis: a case report andliterature review. Infez Med. 2007;15(1): 56–58.

  40. Rusmir AV, Paunescu IA, Martis S, Latcu S,Novacescu D, Bardan CR, et al. EncrustedUretero-Pyelitis Caused by Corynebacteriumurealyticum: Case Report and LiteratureReview. Diagnostics. 2022;12(9): 2239. https://doi.org/10.3390/diagnostics12092239.

  41. Simoons-Smit AM, Savelkoul PHM, NewlingDWW, Vandenbroucke-Grauls CMJ. ChronicCystitis Caused by Corynebacterium urealyticumDetected by Polymerase Chain Reaction.European Journal of Clinical Microbiology &Infectious Diseases. 2000;19(12): 949–952.https://doi.org/10.1007/s100960000407.

  42. Domann E, Hong G, Imirzalioglu C, TurschnerS, Kühle J, Watzel C, et al. Culture-IndependentIdentification of Pathogenic Bacteria andPolymicrobial Infections in the GenitourinaryTract of Renal Transplant Recipients. Journal ofClinical Microbiology. 2003;41(12): 5500–5510.https://doi.org/10.1128/jcm.41.12.5500-5510.2003.

  43. Nadler RB, Hoffman TA, McCLENNANBL, Clayman RV. Corynebacteriumurealyticum(CDC Group D2) Associated withStaghorn Calculus: Treatment by PercutaneousDebulking and Chemolysis. Journal ofEndourology. 1996;10(1): 31–34. https://doi.org/10.1089/end.1996.10.31.

  44. Meria P, Desgrippes A, Fournier R, Arfi C,Antoine C, Martinat L, et al. The conservativemanagement of corynebacterium groupD2 encrusted pyelitis. BJU international.1999;84(3): 270–275. https://doi.org/10.1046/j.1464-410x.1999.00156.x.

  45. Estorc JJ, de La Coussaye JE, Viel EJ, BouzigesN, Ramuz M, Eledjam JJ. Teicoplanintreatment of alkaline encrusted cystitis dueto Corynebacterium group D2. The EuropeanJournal of Medicine. 1992;1(3): 183–184.

  46. Ozkan TA, Yalcin MS, Dillioglugil O, Cevik I.Encrusted cystitis caused by corynebacteriumurealyticum: a case report with novel treatmentstrategy of intravesical dimethyl sulfoxide.International braz j urol. 2018;44(6): 1252–1255. https://doi.org/10.1590/s1677-5538.ibju.2017.0588.

  47. Newman D. The treatment of cystitis byintravesical injections of lactic bacillus cultures.The Lancet. 1915;186(4798): 330–332. https://doi.org/10.1016/S0140-6736(01)53633-8.

  48. Caulk JR. Incrusted cystitis. Am J Urol. 11: 1–10.

  49. Redewill FH. Comparison of leukoplakia,malakoplakia, and incrusted cystitis: reportof cases and a new method of treatment.Journal of the American Medical Association.1929;92(7): 532. https://doi.org/10.1001/jama.1929.02700330016006.

  50. Sabiote L, Emiliani E, Kanashiro AK, Balañà J,Mosquera L, Sánchez-Martín FM, et al. OralAcidification with l-Methionine as a NoninvasiveTreatment for Encrusted Uropathy. Journal ofEndourology Case Reports. 2020;6(3): 143-146.https://doi.org/10.1089/cren.2019.0164.




2020     |     www.medigraphic.com